Kamakura, Japan

Yu Omori

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Toray Industries, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Omori. Retrieved from https://idiyas.com/inventor/yu-omori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Omori: Innovator in Therapeutic Solutions

Introduction

Yu Omori is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of therapeutics, particularly in addressing cachexia associated with ghrelin resistance. His work is crucial in developing effective treatments for this challenging condition.

Latest Patents

Yu Omori holds a patent for a therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance. This innovative agent contains an opioid κ receptor agonist compound, which is represented by a specific formula. The development of this agent addresses a critical need in the medical community for effective treatments for cachexia.

Career Highlights

Yu Omori is affiliated with Toray Industries, Inc., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to focus on innovative solutions in the therapeutic landscape.

Collaborations

Yu collaborates with Masashi Uchida, contributing to the advancement of their shared goals in therapeutic research. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Yu Omori's contributions to the field of therapeutics highlight his dedication to improving patient outcomes. His innovative patent for a therapeutic agent showcases his commitment to addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…